Pharmacogenomics on Individualized Precise Treatment of Patients with Depression

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
PharmacogenomicsDepression
Interventions
DIAGNOSTIC_TEST

Genomic analysis of antidepressants

Genomic analysis of all antidepressants. Tris EDTA anticoagulation and salting out were used to extract DNA. OD 260/280 was between 1.6-1.8 and the concentration was greater than 50 ng/ μ L。 Using the PCR gene chip detection method and the Asian Screening Array (ASA) chip detection technology of Illumina Company (this chip is the first whole genome SNP chip designed based on the whole genome sequencing data of 9000+East Asian populations, which contains 750000 markers, with 85% of the effective loci), we can obtain the genetic information of polymorphic loci related to the individual differences of drug effects of subjects.

Trial Locations (1)

200124

Tongji University, Shanghai

All Listed Sponsors
lead

Tongji University

OTHER